Ortho Clinical Diagnostics, ọkan ninu awọn ile-iṣẹ iwadii vitro ti o tobi julọ ni agbaye, kede ifilọlẹ ti iwọn akọkọ COVID-19 IgG idanwo antibody ati idanwo COVID-19 nucleocapsid antibody kan.
Ortho jẹ ile-iṣẹ nikan ni Amẹrika ti o pese apapọ ti idanwo pipo ati idanwo nucleocapsid fun awọn ile-iṣere.Awọn idanwo mejeeji wọnyi ṣe iranlọwọ fun ẹgbẹ iṣoogun ṣe iyatọ idi ti awọn aporo-ara lodi si SARS-CoV-2 ati ṣe ilana wọn lori eto VITROS® igbẹkẹle Ortho.
“Ni Amẹrika, gbogbo awọn ajesara ti a ṣe ajesara jẹ apẹrẹ lati ṣe agbejade esi antibody si amuaradagba iwasoke ti ọlọjẹ SARS-CoV-2,” Ivan Sargo, MD, Awọn iwadii Iwosan ti Ortho, ori oogun, ile-iwosan ati awọn ọran imọ-jinlẹ sọ.“Idanwo ajẹsara ajẹsara IgG tuntun ti Ortho, papọ pẹlu idanwo antibody tuntun ti nucleocapsid, le pese data afikun lati ṣe iranlọwọ lati pinnu boya idahun antibody wa lati ikolu adayeba tabi ajesara ti o ni idojukọ amuaradagba.”1
Ortho's VITROS® Anti-SARS-CoV-2 IgG quantitative antibody test is the first antibody test in the United States lati pese awọn iye iwọn ni ibamu si awọn ajohunše agbaye ti Ajo Agbaye fun Ilera (WHO).2 Idanwo apakokoro iwọn iwọn ṣe iranlọwọ lati ṣe deede awọn ọna serological SARS-CoV-2 ati gba afiwera data aṣọ ni gbogbo awọn ile-iṣere.Data isokan yii jẹ igbesẹ akọkọ ni oye igbega ati isubu ti awọn aporo ara ẹni kọọkan ati ipa igba pipẹ ti ajakaye-arun COVID-19 lori agbegbe ati gbogbo eniyan lapapọ.
Idanwo iwọn IgG tuntun ti Ortho jẹ apẹrẹ lati ni iwọn ati iwọn wiwọn awọn aporo IgG lodi si SARS-CoV-2 ninu omi ara eniyan ati pilasima, pẹlu pato 100% ati ifamọ to dara julọ.3
Ortho tuntun VITROS® Anti-SARS-CoV-2 Total Nucleocapsid Antibody Idanwo jẹ idanwo 4 ti o peye ga julọ fun wiwa agbara ti SARS-CoV-2 nucleocapsid ninu awọn alaisan ti o ni akoran pẹlu ọlọjẹ SARS-CoV-2 Antibody.
Dokita Chockalingam Palaniappan sọ pe “A n kọ imọ tuntun nigbagbogbo nipa ọlọjẹ SARS-CoV-2 lojoojumọ, ati Ortho ti pinnu lati pese awọn ile-iwosan pẹlu awọn ojutu ti o peye gaan lati ṣe iranlọwọ fun wọn lati koju awọn italaya lọwọlọwọ ati ọjọ iwaju ti ajakale-arun ti o tẹsiwaju,” Dokita Chockalingam Palaniappan sọ. , Oloye Innovation Officer of Ortho Clinical Diagnostics.
Idanwo antibody pipo ti Ortho ti COVID-19 pari ilana ifitonileti lilo pajawiri AMẸRIKA ati Ounjẹ ati Oògùn (FDA) ni Oṣu Karun ọjọ 19, Ọdun 2021, o si fi aṣẹ lilo pajawiri (EUA) silẹ fun idanwo naa si FDA.VITROS® Anti-SARS-CoV-2 lapapọ idanwo antibody nucleocapsid pari ilana EUN ni Oṣu Karun 5, 2021, ati pe o tun fi EUA silẹ.
Ṣe o fẹ lati fi awọn iroyin imọ-jinlẹ tuntun ranṣẹ taara si apo-iwọle rẹ?Di omo egbe SelectScience bayi fun free >>
1. Awọn alaisan ti a ṣe ajesara pẹlu awọn ajesara ọlọjẹ ti ko ṣiṣẹ yoo ṣe agbekalẹ awọn egboogi-N ati awọn egboogi-S.2. https://www.who.int/publications/m/item/WHO-BS-2020.2403 3. 100% pato, 92.4% ifamọ diẹ sii ju 15 ọjọ lẹhin ibẹrẹ ti awọn aami aisan 4. 99.2% pato ati 98.5% PPA ≥ 15 ọjọ lẹhin ibẹrẹ ti awọn aami aisan
Akoko ifiweranṣẹ: Oṣu Keje-22-2021